Mabion is a fully integrated CDMO offering a wide range of services related to the development and production of protein-based biotherapeutics, including monoclonal antibodies and vaccine antigens. With 16 years’ of experience, Mabion offers end-to-end solutions covering all stages of biologic drug development, from early clone selection and small-scale production, through process scale-up, large-scale manufacturing and quality control to sterile fill&finish, bioanalytics and regulatory support.